Related Experiment Video
Updated: May 15, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Plasmapheresis in myeloma cast nephropathy
Isabelle Chapdelaine1, François Madore
1Nephrology Department, Université de Montréal, Montréal, Québec, Canada.
Plasmapheresis, combined with chemotherapy, may improve kidney function in patients with multiple myeloma cast nephropathy. This case study and literature review explore its potential benefits for renal failure.
Area of Science:
- Nephrology
- Hematology
- Oncology
Background:
- Multiple myeloma frequently causes renal failure, often due to cast nephropathy from free light chain precipitation.
- The prognosis for myeloma-associated renal failure is generally poor.
- Plasmapheresis is considered as an adjunctive therapy, but its effectiveness remains debated.
More Related Videos
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management

